- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The only class of oral erectile dysfunction (ED) medication on the market are the phosphodiesterase Type 5 inhibitors (PDE5i). This pilot study is being done to evaluate the effect of Mirabegron, an oral beta-3 adrenergic agonist, on men with both Overactive Bladder (OAB) symptoms and mild to moderate ED.
Critère d'inclusion
- Erectile Dysfunction,Overactive Bladder,Urinary incontinence